We showed that oxaliplatin induces the formation of CHK2/PARP1 and DNA-PKcs/CHK2 complexes, suggesting that oxaliplatin-indued DNA-PKcs/CHK2/PARP1 complex could be one of the mechanisms that activate CHK2/PARP1 signalling in CRC cells. Here, PRKDC is linked to colorectal carcinoma.